Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
2.57B | 2.31B | 2.24B | 2.04B | 1.94B | Gross Profit |
515.20M | 443.80M | 422.80M | 366.20M | 382.00M | EBIT |
197.60M | 182.70M | 158.20M | 107.30M | 151.80M | EBITDA |
197.60M | 383.50M | 501.30M | 251.30M | 263.30M | Net Income Common Stockholders |
93.70M | 159.20M | 245.80M | 69.60M | 106.60M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
187.30M | 104.80M | 160.40M | 72.90M | 95.80M | Total Assets |
4.92B | 3.58B | 3.34B | 3.19B | 2.65B | Total Debt |
1.69B | 568.70M | 550.60M | 679.50M | 254.50M | Net Debt |
1.50B | 463.90M | 390.20M | 606.60M | 158.70M | Total Liabilities |
2.49B | 1.25B | 1.16B | 1.23B | 754.50M | Stockholders Equity |
2.43B | 2.33B | 2.18B | 1.95B | 1.89B |
Cash Flow | Free Cash Flow | |||
312.30M | 57.50M | 36.30M | 81.40M | 177.80M | Operating Cash Flow |
502.00M | 261.00M | 174.30M | 166.50M | 259.90M | Investing Cash Flow |
-1.51B | -285.80M | 90.70M | -570.30M | -528.20M | Financing Cash Flow |
1.09B | -30.80M | -177.50M | 380.90M | 123.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $2.85B | 12.00 | 22.80% | 1.65% | 7.31% | 91.99% | |
76 Outperform | $4.01B | 27.99 | 17.68% | 1.02% | 10.96% | 43.44% | |
74 Outperform | $4.34B | 55.83 | 3.23% | 0.22% | 10.44% | -45.30% | |
72 Outperform | $3.81B | 38.25 | 12.75% | 0.60% | 11.42% | 247.33% | |
68 Neutral | $3.89B | 30.61 | 9.60% | 1.96% | 8.34% | -63.02% | |
64 Neutral | $4.44B | 11.99 | 5.16% | 249.23% | 4.01% | -11.87% | |
56 Neutral | $3.52B | 38.66 | 15.74% | 1.14% | -3.52% | -46.60% |
On May 14, 2025, Arcosa, Inc. held its Annual Meeting of Shareholders where key proposals were voted upon, including the election of directors and the approval of executive compensation. The shareholders also ratified Ernst & Young LLP as the independent registered public accounting firm for the year ending December 31, 2025. Additionally, Arcosa has updated its investor presentation materials to reflect its ongoing strategic transformation, focusing on margin expansion, cash flow generation, and growth in attractive markets. The company has made significant investments in its construction products platform, including the acquisition of Stavola, to enhance its market positioning and reduce business complexity.
The most recent analyst rating on (ACA) stock is a Buy with a $105.00 price target. To see the full list of analyst forecasts on Arcosa stock, see the ACA Stock Forecast page.
Spark’s Take on ACA Stock
According to Spark, TipRanks’ AI Analyst, ACA is a Outperform.
Arcosa receives an overall score of 70, reflecting its strong financial performance and optimistic earnings call outlook. However, the overvaluation concerns and mixed technical indicators slightly temper the score. The company’s ability to manage rising debt levels and leverage its acquisitions effectively will be key to maintaining its financial health.
To see Spark’s full report on ACA stock, click here.